Hyperlipoproteinemia Type
📧 Sign up to get email alerts when something new happens for Hyperlipoproteinemia Type.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-03EMA Authorised: Redemplo (plozasiran sodium) — Arrowhead Pharmaceuticals Ireland Limited
EMA has authorised Redemplo (plozasiran sodium) from Arrowhead Pharmaceuticals Ireland Limited for Hyperlipoproteinemia Type I.
-
EMA approval · 2026-03-23EMA Authorised: Waylivra (volanesorsen sodium) — Akcea Therapeutics Ireland Limited
The European Medicines Agency authorised Waylivra (volanesorsen) for Hyperlipoproteinemia Type I, under conditional approval with orphan des…
-
EMA approval · 2025-12-03EMA Authorised: Tryngolza (olezarsen sodium) — Swedish Orphan Biovitrum AB (publ)
The European Medicines Agency authorised Tryngolza (olezarsen sodium) from Swedish Orphan Biovitrum AB (publ) for hyperlipoproteinemia type …
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Atlantic Lipid Lowering Treatment Optimization Program [NA]
Clinical Trial Update for the Atlantic Lipid Lowering Treatment Optimization Program (NCT06439654) shows recruiting status for multiple lipi…
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia [Phase 2]
Ongoing Phase 2 clinical trial evaluating the long-term efficacy and safety of Orlistat for hyperlipoproteinemia Type I, currently recruitin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Orlistat for the Treatment of Type I Hyperlipoproteinemia [Phase 2]
Phase 2 trial update evaluating orlistat for treating Hyperlipoproteinemia Type I and related hypertriglyceridemia conditions.
-
EMA withdrawal · 2017-10-30EMA Expired: Glybera (alipogene tiparvovec) — uniQure biopharma B.V.
Glybera (alipogene tiparvovec) has expired status for Hyperlipoproteinemia Type I according to EMA, indicating withdrawal from active regula…
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia [Phase 2]
A Phase 2 pilot study evaluating CAT-2003 for familial chylomicronemia syndrome and related lipid disorders has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies
This clinical trial update discusses the duration of effect of alipogene tiparvovec (Glybera) when given in previous studies for Hyperlipopr…
-
CLINICAL_TRIALS trial_result · 2010-06-08Clinical Trial Update: Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients [Phase 4]
Phase 4 clinical trial evaluating rosuvastatin's effect on triglyceride levels in Mexican patients with hypertriglyceridemia; results have b…